<ѻýҕl>PARP Inhibitors Linked With Blood Cancer Riskѻýҕl> Incidence of MDS/AML under 1%, but further investigation warranted as indications broaden Dec 28, 2020
<ѻýҕl>Immunotherapy Falls Short Again in Ovarian Cancerѻýҕl> No PFS benefit in advanced disease with addition of atezolizumab to chemo, bevacizumab Sep 23, 2020
<ѻýҕl>Which Women Choose Hormones for Surgical Menopause?ѻýҕl> Understanding patterns of use can help improve targeting for education and counseling, researchers say Aug 12, 2020
<ѻýҕl>Second Surgery Gets OS Win in Recurrent Ovarian Cancerѻýҕl> Survival improved by nearly 8 months with cytoreductive surgery at first relapse Jun 02, 2020
<ѻýҕl>Avelumab Flops Again in Ovarian Cancerѻýҕl> Another negative phase III trial, now in the first-line setting May 19, 2020
<ѻýҕl>PARP Inhibitors Still Work in HRD-Low Ovarian Cancerѻýҕl> In VELIA, homologous recombination deficiency score prognostic but not predictive May 14, 2020
<ѻýҕl>KRAS May Predict Benefit of MEK Inhibitors in Some Ovarian Cancersѻýҕl> Nearly 7-month PFS boost in patients with KRAS mutations May 11, 2020
<ѻýҕl>New Standard in Recurrent, Platinum-Sensitive Ovarian Cancerѻýҕl> Pegylated liposomal doxorubicin unseats gemcitabine in standard platinum regimen Apr 21, 2020
<ѻýҕl>Breastfeeding Tied to Lower Ovarian Cancer Riskѻýҕl> Lower incidence of borderline tumors as well Apr 02, 2020
<ѻýҕl>Post-Op HPV Vaccine Cuts Cervical Precancer Recurrencesѻýҕl> Plus osteoporosis in gynecologic cancer survivors, and a novel approach to CIN2/3 Mar 31, 2020
<ѻýҕl>DOAC Works in Cancer-Related VTE, No Tradeoff in Bleedsѻýҕl> Apixaban monotherapy matches dalteparin in non-inferiority trial Mar 29, 2020
<ѻýҕl>After Five Months in a Coma, Young Nurse Wakes Upѻýҕl> Chicago RN with rare autoimmune encephalitis responds to unusual treatment Jan 10, 2020
<ѻýҕl>Trametinib Tx Shows Promise in Tough-to-Treat LGSOCѻýҕl> Targeted drug provokes good response in chemoresistant, low-grade serous ovarian or peritoneal cancer Sep 30, 2019
<ѻýҕl>Data Support 'Best Drug First' in EGFR-Mutant NSCLCѻýҕl> Six-month survival gain with osimertinib, adding to PFS, safety advantages Sep 29, 2019
<ѻýҕl>PARP Inhibitors: The Key to a Tx Paradigm Shift in Ovarian Ca?ѻýҕl> PRIMA and VELIA trial findings advance niraparib and veliparib to the therapeutic front lines Sep 29, 2019
<ѻýҕl>First-Line Combo Boosts PFS in Advanced Ovarian Caѻýҕl> Olaparib-bevacizumab maintenance boosts PARP inhibitor benefits beyond BRCA-mutated subgroup Sep 28, 2019
<ѻýҕl>Obamacare Cut Racial Disparities in Cancer Careѻýҕl> Time to cancer treatment evens in blacks and whites with Medicaid expansion Jun 03, 2019
<ѻýҕl>Birth Control Pills Tied to Reduced Risk of Deadly Ovarian Caѻýҕl> Every 5 years of use linked with 32% reduction in risk of dying within 12 months of diagnosis Apr 04, 2019 video
<ѻýҕl>Early Data Send Strong Signal in Advanced Gyn Cancersѻýҕl> Clinical benefit rate tops 90% in pair of single-center studies Mar 19, 2019
<ѻýҕl>'End of the Road' for Trabectedin in Ovarian Cancer?ѻýҕl> Trial stopped for futility, but 13-month OS improvement seen in patients with BRCA mutations Mar 19, 2019
<ѻýҕl>When PARP Inhibitors Fail in Ovarian Cancerѻýҕl> Study identifies subgroup for whom another go could be worthwhile Mar 18, 2019
<ѻýҕl>Avelumab Combo Falls Short in Advanced Ovarian Caѻýҕl> But showed promise in PD-L1-positive group Mar 18, 2019
<ѻýҕl>PARP Inhibitor Benefit Gets a TWiST in Recurrent Ovarian Caѻýҕl> Analysis attempts to quantify patients' quality of survival Mar 17, 2019
<ѻýҕl>Lymphadenectomy Often Useless in Ovarian Cancerѻýҕl> No survival benefit with normal nodes after complete macroscopic resection Mar 01, 2019
<ѻýҕl>Surgery/HIPEC Safer Than Other High-Risk Cancer Proceduresѻýҕl> Lower infection, 30-day mortality rates than with Whipple, esophagectomy Jan 15, 2019
<ѻýҕl>Does Johnson's Baby Powder Cause Cancer?ѻýҕl> Milton Packer says the $4.69-billion verdict is about anger, not medicine Jan 09, 2019
<ѻýҕl>Simple Ovarian Cysts Hold No Cancer Riskѻýҕl> Malignancy extremely rare, don't need surveillance Nov 12, 2018
<ѻýҕl>Practice-Changing PARP Inhibitor Study in Ovarian Cancerѻýҕl> "Unprecedented" increase in PFS with upfront olaparib maintenance Oct 21, 2018
<ѻýҕl>Serena Williams: Women's Healthcare Hero?ѻýҕl> Yes! She's a champ on the tennis court and could prevent maternal death Aug 02, 2018
<ѻýҕl>Cancer Linked to Infertility in Men and Womenѻýҕl> Assisted reproductive technology not to blame, researchers say Jul 03, 2018
<ѻýҕl>PFS Rises in Ovarian Ca with Repeat Bevacizumabѻýҕl> Magnitude of benefit similar to first-line therapy Jun 06, 2018
<ѻýҕl>Women Do Well Without Opioids after Gyn Surgeryѻýҕl> An 89% drop in opioid use with restrictive prescribing protocol Mar 26, 2018
<ѻýҕl>Gyn Cancer Research Gets Short Shrift in Fundingѻýҕl> Mortality-adjusted analysis shows huge disparity versus other cancers Mar 25, 2018
<ѻýҕl>Possible Chlamydia Link with Ovarian Cancerѻýҕl> Associations seen in two separate cohorts of women Mar 19, 2018
<ѻýҕl>Telemedicine OK for Genetic Testing and Counselingѻýҕl> Trial finds no major difference in psychosocial outcomes Aug 09, 2017
<ѻýҕl>No Survival Benefit with Node Dissection in Ovarian Caѻýҕl> Macroscopic complete resection drives outcomes Jun 07, 2017
<ѻýҕl>Advanced Ca Patients Benefit from Online Symptom Reportsѻýҕl> Patient-reported outcomes tied to increased survival Jun 05, 2017
<ѻýҕl>Second Surgery Slows Recurrent Ovarian Cancerѻýҕl> But no survival gain seen in interim analysis of DESKTOP III Jun 03, 2017
<ѻýҕl>HPV-Targeted Drug Sets Survival Mark in Cervical Cancerѻýҕl> Highest-ever 12-month survival in recurrent, metastatic disease Mar 15, 2017
<ѻýҕl>MSK Cancer Alliance: Mainly About Medicineѻýҕl> Bi-directional relationship strengthens regional cancer care Mar 11, 2017